Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 4 33-4, 2005, Pages

  Shetty, Sreerama ^a,b   Ganachari, Malathesha ^a   Liu, Ming Cheh ^a   Azghani, Ali ^a   Muniyappa, Harish ^a   Idell, Steven ^a  

^a Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Messenger ribonucleic acid binding proteins; Messenger ribonucleic acid stability

Indexed keywords

1,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE DIPHOSPHATE; FUNCTIONAL GROUP; GLYCERIC ACID; MESSENGER RNA; MESSENGER RNA BINDING PROTEIN; MUTANT PROTEIN; PHOSPHOGLYCERATE KINASE; PHOSPHORYL GROUP; POSTTRANSCRIPTIONAL CONTROL; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER CELL CULTURE; CATALYSIS; CELL INVASION; CELL MIGRATION; CELL STRAIN; CELL STRAIN H157; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; EPICURIAN COLI BL21; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GLYCOLYSIS; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA STABILITY; RNA SYNTHESIS; RUN ON TRANSCRIPTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

CARCINOMA, SQUAMOUS CELL; CATALYSIS; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CLONING, MOLECULAR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PHOSPHOGLYCERATE KINASE; RECEPTORS, CELL SURFACE; RNA STABILITY; RNA, MESSENGER;

EID: 25444445568     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00319.2004     Document Type: Article

References (48)

1. Adam H. Adenosine-5-diphosphate and adenosine-5-monophosphate. In: Methods of Enzymatic Analysis, edited by Bergmeyer HU. New York: Academic, 1965, p. 573-577.
2. Bhat GJ, Gunaje JJ, and Idell S. Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells. Am J Physiol Lung Cell Mol Physiol 277: L301-L309, 1999.
3. Blasi F, Vassalli JD, and Dano K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol 104: 801-804, 1987.
4. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 9: 714-724, 1997.
5. Chu E, Takimoto CH, Voeller D, Grem JL, and Allegra CJ. Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro. Biochemistry 32: 4756-4760, 1993.
6. Chu E, Voeller D, Koeller DM, Drake JC, Takimoto CH, Maley GF, Maley F, and Allegra CJ. Identification of an RNA binding site for human thymidylate synthase. Proc Natl Acad Sci USA 90: 517-521, 1993.
7. Clerch LB, Wagner A, and Massaro D. Dinucleotide-binding site of bovine liver catalase mimics a catalase mRNA-binding protein domain. Am J Physiol Lung Cell Mol Physiol 270: L790-L794, 1996.
8. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, and Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139-266, 1985.
9. Dano K, Behrendt N, Brunner N, Ellis V, Ploug M, and Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 8: 189-203, 1994.
10. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
11. Dvorak HF, Senger DR, and Dvorak AM. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev 2: 41-73, 1983.
12. Elzigna SDJ, Bednarz AL, von Oosterum K, Dekkar PJT, and Grivell LA. Yeast mitochondrial NAD(+)-dependent isocitrate dehydrogenase is an RNA-binding protein. Nucleic Acids Res 21: 5328-5331, 1993.
13. Ghiso JAA, Alonso DF, Farias EF, Gomez DE, and Bal de Kier Joffe E. Deregulation of the signaling pathways controlling urokinase production: its relationship with the invasive phenotype. Eur J Biochem 263: 295-304, 1999.
14. Haran G, Haas E, Szpikowska BK, and Mas MT. Domain motions in phosphoglycerate kinase: determination of interdomain distance distributions by site-specific labeling and time-resolved fluorescence energy transfer. Proc Natl Acad Sci USA 89: 11764-11768, 1992.
15. Hentze MW. Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains? Trends Biochem Sci 19: 101-103, 1994.
16. Liotta LA, Stetler-Stevenson WG, and Steeg PS. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9: 543-551, 1991.
17. Lund LR, Ellis V, Ronne E, Pyke C, and Dano K. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumor promoters in the human lung carcinoma cell line A549. Biochem J 310: 345-352, 1995.
18. Lund LR, Ronne E, Roldan AL, Behrendt N, Romer J, Blasi F, and Dano K. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J Biol Chem 266: 5177-5181, 1991.
19. Mazar AP, Henkin J, and Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 3: 15-32, 1999.
20. McHarg J, Kelly SM, Price NC, Cooper A, and Littlechild JA. Site-directed mutagenesis of praline 204 in the "hinge" region of yeast phosphoglycerate kinase. Eur J Biochem 259: 939-945, 1999.
21. Michelson AM, Markham AF, and Orkin SH. Isolation and DNA sequence of a full-length cDNA clone for human X chromosome-encoded phosphoglycerate kinase. Proc Natl Acad Sci USA 80: 472-476, 1983.
22. Mignatti P and Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
23. Montuori N, Salzano S, Rossi G, and Ragno P. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor. FEBS Lett 476: 166-170, 2000.
24. Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, and Deppert W. Negative feed back regulation of wild-type p53 biosynthesis. EMBO J 14: 4442-4449, 1995.
25. Nagakawa J, Waldner H, Meyer SM, Hofsteenege J, Jeno P, and Moroni C. AUH, agene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc Natl Acad Sci USA 92: 2051-2055, 1995.
26. Nagy E and Rigby WF. Glyceradehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD (+)-binding region (Rossman fold). J Biol Chem 270: 2755-2763, 1995.
27. Nanbu R, Kubo T, Hashimoto T, and Natori S. Purification of an AU-rich RNA binding protein from sarcophagi peregrina (flesh fly) and its identification as a thiolase. J Biochem (Tokyo) 114: 432-437, 1993.
28. Pedersen H, Brunner N, Francis D, Osterlind K, Ronne E, Hansen HH, Dano K, and Grondahl-Hansen J. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 54: 4671-4675, 1994.
29. Pedersen H, Grondahl-Hansen J, Francis D, Osterlind K, Hansen HH, Dano K, and Brunner N. Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma. Cancer Res 54: 120-123, 1994
30. Pepper MS, Matsumoto K, Nakamura T, Orci L, and Montesano R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem 267: 20493-20496, 1992.
31. Pioli PA, Hamilton BJ, Connolly JE, Brewer G, and Rigby WFC. Lactate dehydrogenase is an AU-rich element binding protein that directly interacts with AUF1. J Biol Chem 277: 35738-35745, 2002.
32. Preiss T, Hall AG, and Lighowlers RN. Identification of bovine glutamate dehydrogenase as an RNA-binding protein. J Biol Chem 268: 24523-24526, 1993
33. Rouault TA, Stout CD, Kaptain S, Harford JB, and Klausner RD. Structural relationship between an iron-regulated RNA-binding protein (IRE-BP) and aconitase: functional implications. Cell 64: 881-883, 1991.
34. Saksela O and Riffkin DB. Cell associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4: 93-126, 1988.
35. Shetty S and Well S. Urokinase receptor mRNA stability involves tyrosine phosphorylation in lung epithelial cells. Am J Respir Cell Mol Biol 30: 69-75, 2004.
36. Shetty S, Kumar A, Johnson A, and Idell S. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides by antisense oligonucleotides for the urokinase receptor. Antisense Res Dev 5: 307-314, 1995.
37. Shetty S and Idell S. Posttranscriptional regulation of urokinase receptor gene expression in lung carcinoma and malignant mesothelioma cells in vitro. Mol Cell Biochem 199: 189-200, 1999.
38. Shetty S and Idell S. Urokinase induces expression of its own receptor in Beas2B lung epithelial cells. J Biol Chem 276: 24549-24556, 2001.
39. Shetty S, Kumar A, and Idell S. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 17: 1075-1083, 1997.
40. Shetty S, Kumar A, Johnson A, Pueblitz S, and Idell S. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol Lung Cell Mol Physiol 268: L972-L982, 1995.
41. Shetty S, Muniyappa H, Halady PKS, and Idell S. Regulation of urokinase receptor expression by phosphoglycerate kinase. Am J Respir Cell Mol Biol 31: 100-106, 2004.
42. Sprengers ED and Kluft C. Plasminogen activator inhibitors. Blood 69: 381-387, 1987.
43. Vassalli JD. The urokinase receptor. Fibrinolysis 8: 172-181, 1994.
44. Vassalli JD, Sappino AP, and Belin D. The plasminogen activator/plasmin system. J Clin Invest 88: 1067-1072, 1991.
45. Waltz DA, Sailor LZ, and Chapman HA. Cytokines induce urokinase-dependent adhesion of human myeloid cells. J Clin Invest 91: 1541-1552, 1993.
46. Wang GJ, Collinge M, Blasi F, Pardi R, and Bender JR. Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. Proc Natl Acad Sci USA 95: 6296-6301, 1998.
47. Wang Y, Jones CJ, Dang J, Liang X, Olsen JE, and Doe WF. Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells. FEBS Lett 353: 138-142, 1994.
48. Xing RH, Mazar A, Henkin J, and Rabbani SA. Prevention of breast cancer growth, invasion, and metastasis by anti-estrogen tamoxifen alone or in combination with urokinase inhibitor B-428. Cancer Res 57: 3585-3593, 1997.